缺血性心脏病的心肌血流量评估与报告:心脏PET、MR、CT与超声心动图
专家小组综述了PET心肌灌注成像联合示踪剂动力学模型可同时评估心肌血流量(MBF),心脏MR、CT和超声心动图是新兴的MBF定量技术。充血态和静息态MBF及心肌血流储备的定量拓展了常规心肌灌注成像的诊断范围,标准化算法对优化诊断和治疗决策至关重要。
要点
- PET心肌灌注成像联合示踪剂动力学模型可同时评估以mL/min/g组织为单位的心肌血流量。
- 心脏MR、CT和超声心动图是能够定量MBF的新兴技术。
- 充血态和静息态MBF及心肌血流储备的定量拓展了常规心肌灌注成像的诊断范围。
核心结论
- MBF定量将常规心肌灌注成像的诊断范围从检出多支冠状动脉疾病中最严重且限流的心外膜病变,拓展至较轻的中度心外膜病变、准确描绘多支冠状动脉疾病缺血负荷的范围和严重程度,以及检测归因于冠状动脉疾病或冠状动脉小动脉水平的弥漫性缺血。
- 除改善缺血性心脏病的诊断范围外,MBF的额外定量还可用于随访治疗干预、危险因素调整和/或生活方式改变的治疗成功情况,这些可能改善长期心血管结局。
- 每种成像模态在缺血性心脏病诊断和报告中的标准化算法似乎对优化此类患者的诊断和治疗决策至关重要。
研究设计与样本
- 专家小组综述,旨在简要概述缺血性心脏病的病理生理学及其使用不同成像模态的无创评估。
临床应用与阅片要点
- 专家小组力求提供缺血性心脏病病理生理学及其使用不同成像模态无创评估的简要概述,这些可能对诊断各种类型的缺血性心脏病至关重要。
- 专家小组力求提供个体化和图像引导的患者护理,可能进一步优化心血管结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Positron emission tomographic myocardial perfusion imaging in conjunction with tracer-kinetic modeling affords the concurrent assessment of myocardial blood flow (MBF) in mL/min/g of tissue. Cardiac magnetic resonance, computed tomography, and echocardiography are emerging technologies capable of MBF quantification. The noninvasive evaluation and quantification of MBF during hyperemia and at rest and corresponding myocardial flow reserve expand the realm of conventional myocardial perfusion imaging from detection of the most advanced, and flow-limiting, epicardial lesions in multivessel coronary artery disease (CAD) to less severe intermediate epicardial lesions, accurate delineation of the extent and severity of ischemic burden in multivessel CAD, detection of diffuse ischemia attributable to CAD or at coronary arteriolar level such as in hypertrophic cardiomyopathy, transplantation vasculopathy, and coronary microvascular dysfunction in its classical and/or endogen forms. Apart from improving the diagnostic scope in ischemic heart disease, the additional quantitation of MBF also affords the contingency to follow-up on treatment success of therapeutic interventions, risk factor modifications, and/or lifestyle changes likely to improve long-term cardiovascular outcomes. Standardized algorithms for each imaging modality in the diagnosis and reporting of ischemia heart disease appear critical for optimized diagnosis and treatment decisions in such patients. In this respect, the convened expert panel strives to provide a concise overview of the pathophysiology of ischemic heart disease and its noninvasive assessment with different imaging modalities that may be pivotal for the diagnosis of various pattern types of ischemic heart disease, as well as individualized and image-guided patient care likely to further optimize cardiovascular outcome.
引用
- Schindler TH, Arai AE, Berry C, et al. Myocardial Blood Flow Assessment and Reporting for Ischemic Heart Disease: Cardiac PET, MR, CT, and Echocardiography. JACC Cardiovasc Imaging. 2025. PMID: 41148068. doi:10.1016/j.jcmg.2025.08.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。